Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University of Campinas, Brazil clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Brazil register with University of Campinas, Brazil as lead sponsor. Synced 16 Nov 2026
10Current trials
4Recruiting now
1Drug in these trials
1Trial register
At a glance

University of Campinas, Brazil is the lead sponsor of 10 current clinical trials in our Brazil register. 4 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Dapagliflozin. The most-studied condition is Periodontitis.

ClinicalTrials.gov trials by status

  • Recruiting440%
  • Not yet open220%
  • Active, closed330%
  • By invitation110%

Trials by phase

  • Not applicable660%
  • Observational220%
  • Phase 1110%
  • Phase 3110%
01

Clinical trials sponsored by University of Campinas, Brazil

10 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Effects of a Pulmonary and Cardiovascular Rehabilitation Program
NCT06772922 · ClinicalTrials.gov ↗ · Respiratory Muscle Weakness, Quality of Lifte, Dyspnea; Asthmatic
Not applicable Recruiting 2019-03 Brazil
Resistant Hypertension An Open, Complicated ("Cum Plicare") or Complex ("Cum Plexus") Syndrome?
NCT06450327 · ClinicalTrials.gov ↗ · Hypertension, Resistant Hypertension
Observational Recruiting 2024-08 Brazil
Influence of Zirconia Abutments on Peri-Implant Tissues in Single-Tooth Restorations
NCT07456163 · ClinicalTrials.gov ↗ · Peri-Implant Health, Implant Complication, Prosthesis and Implants
Not applicable Recruiting 2025-04 Brazil
Effect of DAPAglifozin on MYOcardial Remodeling of Breast CANCER Patients Treated with Anthracycline Based Chemotherapy
NCT06711185 · ClinicalTrials.gov ↗ · Breast Cancer
Phase 3 Recruiting 2024-01 Brazil
Structural and Clinical Predictors of Cognitive Impairment After Surgical Treatment for Ruptured Cerebral Aneurysms
NCT07723131 · ClinicalTrials.gov ↗ · Subarachnoid Aneurysm Hemorrhage, Microsurgery, Cognitive Impairment
Observational Not yet open 2026-08 Brazil
Pharmacokinetics of Zoledronic Acid in Patients on Dialysis
NCT07741136 · ClinicalTrials.gov ↗ · Chronic Kidney Disease, Osteoporosis, Dialysis
Phase 1 Not yet open 2026-08 Brazil
Assessment of Tooth Mobility After Non-surgical Periodontal Treatment Followed by Tooth Splinting
NCT06929676 · ClinicalTrials.gov ↗ · Periodontal Diseases, Periodontitis
Not applicable By invitation 2025-04 Brazil
MIST Versus M-MIST for the Treatment of Intrabony Defects
NCT06058923 · ClinicalTrials.gov ↗ · Periodontitis, Intrabony Periodontal Defect, Periodontitis, Chronic
Not applicable Active, closed 2023-08 Brazil
Evaluation of Implantoplasty in the Treatment of Peri-Implantitis.
NCT06884475 · ClinicalTrials.gov ↗ · Peri-Implantitis and Peri-implant Mucositis
Not applicable Active, closed 2025-04 Brazil
Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer
NCT05315154 · ClinicalTrials.gov ↗ · Breast Cancer
Not applicable Active, closed 2019-10 Brazil

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in University of Campinas, Brazil trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in University of Campinas, Brazil trials

21 conditions
Periodontitis2Breast Cancer2Intrabony Periodontal Defect1Periodontitis, Chronic1Respiratory Muscle Weakness1Quality of Lifte1Dyspnea; Asthmatic1Dyspnea; Cardiac1Peri-Implantitis and Peri-implant Mucositis1Hypertension1Resistant Hypertension1Peri-Implant Health1Implant Complication1Prosthesis and Implants1Periodontal Diseases1Subarachnoid Aneurysm Hemorrhage1Microsurgery1Cognitive Impairment1Chronic Kidney Disease1Osteoporosis1Dialysis1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Brazil104

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Periodontitis

SponsorTrials
Postgraduate Institute of Dental Sciences Rohtak6
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University4
Recep Tayyip Erdogan University Training and Research Hospital4
Saglik Bilimleri Universitesi4
University of Sao Paulo4
Universidad de Murcia3
Suleyman Demirel University3
University of L'Aquila2
University of Pisa2
University of Catania2

Sponsors with the most current trials registered for this condition.

06

Questions about University of Campinas, Brazil trials

How many clinical trials does University of Campinas, Brazil sponsor?

University of Campinas, Brazil is the lead sponsor of 10 current trials on ClinicalTrials.gov in our Brazil register, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are University of Campinas, Brazil trials recruiting?

Yes. 4 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University of Campinas, Brazil testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Dapagliflozin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.